189 related articles for article (PubMed ID: 12873488)
1. Design, synthesis and antimalarial activity of novel, quinoline-based, zinc metallo-aminopeptidase inhibitors.
Flipo M; Florent I; Grellier P; Sergheraert C; Deprez-Poulain R
Bioorg Med Chem Lett; 2003 Aug; 13(16):2659-62. PubMed ID: 12873488
[TBL] [Abstract][Full Text] [Related]
2. Novel selective inhibitors of the zinc plasmodial aminopeptidase PfA-M1 as potential antimalarial agents.
Flipo M; Beghyn T; Leroux V; Florent I; Deprez BP; Deprez-Poulain RF
J Med Chem; 2007 Mar; 50(6):1322-34. PubMed ID: 17326615
[TBL] [Abstract][Full Text] [Related]
3. Aminobenzosuberone derivatives as PfA-M1 inhibitors: Molecular recognition and antiplasmodial evaluation.
Salomon E; Schmitt M; Mouray E; McEwen AG; Bounaadja L; Torchy M; Poussin-Courmontagne P; Alavi S; Tarnus C; Cavarelli J; Florent I; Albrecht S
Bioorg Chem; 2020 May; 98():103750. PubMed ID: 32182520
[TBL] [Abstract][Full Text] [Related]
4. New Potential Antimalarial Agents: Design, Synthesis and Biological Evaluation of Some Novel Quinoline Derivatives as Antimalarial Agents.
Radini IA; Elsheikh TM; El-Telbani EM; Khidre RE
Molecules; 2016 Jul; 21(7):. PubMed ID: 27428939
[TBL] [Abstract][Full Text] [Related]
5. Potent dual inhibitors of Plasmodium falciparum M1 and M17 aminopeptidases through optimization of S1 pocket interactions.
Drinkwater N; Vinh NB; Mistry SN; Bamert RS; Ruggeri C; Holleran JP; Loganathan S; Paiardini A; Charman SA; Powell AK; Avery VM; McGowan S; Scammells PJ
Eur J Med Chem; 2016 Mar; 110():43-64. PubMed ID: 26807544
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro antiplasmodial activity of ferrocenyl aminoquinoline derivatives.
Mwande Maguene G; Lekana-Douki JB; Mouray E; Bousquet T; Grellier P; Pellegrini S; Toure Ndouo FS; Lebibi J; Pélinski L
Eur J Med Chem; 2015 Jan; 90():519-25. PubMed ID: 25486423
[TBL] [Abstract][Full Text] [Related]
7. KBE009: An antimalarial bestatin-like inhibitor of the Plasmodium falciparum M1 aminopeptidase discovered in an Ugi multicomponent reaction-derived peptidomimetic library.
González-Bacerio J; Maluf SEC; Méndez Y; Pascual I; Florent I; Melo PMS; Budu A; Ferreira JC; Moreno E; Carmona AK; Rivera DG; Alonso Del Rivero M; Gazarini ML
Bioorg Med Chem; 2017 Sep; 25(17):4628-4636. PubMed ID: 28728898
[TBL] [Abstract][Full Text] [Related]
8. Quinoline hybrids and their antiplasmodial and antimalarial activities.
Hu YQ; Gao C; Zhang S; Xu L; Xu Z; Feng LS; Wu X; Zhao F
Eur J Med Chem; 2017 Oct; 139():22-47. PubMed ID: 28800458
[TBL] [Abstract][Full Text] [Related]
9. Mapping the Pathway and Dynamics of Bestatin Inhibition of the Plasmodium falciparum M1 Aminopeptidase PfA-M1.
Yang W; Riley BT; Lei X; Porebski BT; Kass I; Buckle AM; McGowan S
ChemMedChem; 2018 Dec; 13(23):2504-2513. PubMed ID: 30318749
[TBL] [Abstract][Full Text] [Related]
10. In vitro antimalarial activity, β-haematin inhibition and structure-activity relationships in a series of quinoline triazoles.
Joshi MC; Wicht KJ; Taylor D; Hunter R; Smith PJ; Egan TJ
Eur J Med Chem; 2013 Nov; 69():338-47. PubMed ID: 24077524
[TBL] [Abstract][Full Text] [Related]
11. Quinoline carboxamide core moiety-based compounds inhibit P. falciparumfalcipain-2: Design, synthesis and antimalarial efficacy studies.
Singh A; Kalamuddin M; Maqbool M; Mohmmed A; Malhotra P; Hoda N
Bioorg Chem; 2021 Mar; 108():104514. PubMed ID: 33280833
[TBL] [Abstract][Full Text] [Related]
12. Peptidomimetic inhibitors of protein farnesyltransferase show potent antimalarial activity.
Ohkanda J; Lockman JW; Yokoyama K; Gelb MH; Croft SL; Kendrick H; Harrell MI; Feagin JE; Blaskovich MA; Sebti SM; Hamilton AD
Bioorg Med Chem Lett; 2001 Mar; 11(6):761-4. PubMed ID: 11277514
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of some indolo[3,2-c]quinolines with antimalarial activity.
Go M; Ngiam T; Tan AL; Kuaha K; Wilairat P
Eur J Pharm Sci; 1998 Jan; 6(1):19-26. PubMed ID: 16256704
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, Antimalarial Activity and Docking Study of 7-Chloro-4- (2-(substituted benzylidene)hydrazineyl)quinolines.
Kalita J; Chetia D; Rudrapal M
Med Chem; 2020; 16(7):928-937. PubMed ID: 31385774
[TBL] [Abstract][Full Text] [Related]
15. A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline.
Davioud-Charvet E; Delarue S; Biot C; Schwöbel B; Boehme CC; Müssigbrodt A; Maes L; Sergheraert C; Grellier P; Schirmer RH; Becker K
J Med Chem; 2001 Nov; 44(24):4268-76. PubMed ID: 11708927
[TBL] [Abstract][Full Text] [Related]
16. 2,3,8-Trisubstituted Quinolines with Antimalarial Activity.
Martinez PDG; Krake SH; Poggi ML; Campbell SF; Willis PA; Dias LC
An Acad Bras Cienc; 2018; 90(1 Suppl 2):1215-1231. PubMed ID: 29791525
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships amongst 4-position quinoline methanol antimalarials that inhibit the growth of drug sensitive and resistant strains of Plasmodium falciparum.
Milner E; McCalmont W; Bhonsle J; Caridha D; Carroll D; Gardner S; Gerena L; Gettayacamin M; Lanteri C; Luong T; Melendez V; Moon J; Roncal N; Sousa J; Tungtaeng A; Wipf P; Dow G
Bioorg Med Chem Lett; 2010 Feb; 20(4):1347-51. PubMed ID: 20097070
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and in vitro antiplasmodial activity of some bisquinolines against chloroquine-resistant strain.
Kondaparla S; Agarwal P; Srivastava K; Puri SK; Katti SB
Chem Biol Drug Des; 2017 Jun; 89(6):901-906. PubMed ID: 27896925
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of the antiplasmodial activity of novel indeno[2,1-c]quinoline derivatives.
Barteselli A; Parapini S; Basilico N; Mommo D; Sparatore A
Bioorg Med Chem; 2014 Nov; 22(21):5757-65. PubMed ID: 25311562
[TBL] [Abstract][Full Text] [Related]
20. Quinoline Containing Side-chain Antimalarial Analogs: Recent Advances and Therapeutic Application.
Joshi MC; Egan TJ
Curr Top Med Chem; 2020; 20(8):617-697. PubMed ID: 31985377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
